. Show Affiliations »
Abstract
Mesh: See more » AnimalsClinical Trials as TopicGlial Cell Line-Derived Neurotrophic Factor/therapeutic useHealth Services Accessibility/legislation & jurisprudenceHuman RightsHumansParkinson Disease/drug therapyPatient Advocacy/legislation & jurisprudencePatient Rights/legislation & jurisprudenceUnited States
Substances: See more » Glial Cell Line-Derived Neurotrophic Factor
Year: 2005 PMID: 16297831 DOI: 10.1016/S1474-4422(05)70228-3
Source DB: PubMed Journal: Lancet Neurol ISSN: 1474-4422 Impact factor: 44.182